Creon
Pancrelipase
| Registration | FEI | Name | Status | Initial importer | Expiration year | Address |
|---|---|---|---|---|---|---|
| 3010757606 | 3010757606 | AbbVie Inc | 1 | N | 2026-01-01 | 1 N Waukegan Rd North Chicago IL US 60064 |
| Registration key | Listing key | Premarket submission | Device | Product code | Decision date |
|---|---|---|---|---|---|
| 167405 | 1533216337 | K142816 | AbbVie J | KNT | 2015-01-14 |
| 167405 | 1063894060 | K142793 | AbbVie PEG | KNT | 2015-01-14 |
| 167405 | 1455259871 | K142792 | AbbVie NJ | KNT | 2015-01-14 |
| 167405 | 1681490062 |
| Product code | Registration listing records | Latest decision |
|---|---|---|
| KNT | 3 | 2015-01-14 |
Pancrelipase
Pancrelipase
Pancrelipase
Pancrelipase
Pancrelipase
Pancrelipase
Pancrelipase
Pancrelipase
Pancrelipase
Pancrelipase
Elagolix
Elagolix
Adalimumab
Adalimumab
foscarbidopa/foslevodopa
Lopinavir and Ritonavir
Adalimumab
Venetoclax
Venetoclax
Venetoclax
Venetoclax
Adalimumab
Adalimumab
Elagolix and Estradiol and Norethisterone
Beractant
Upadacitinib
Telisotuzumab Vedotin
risankizumab-rzaa
Telisotuzumab Vedotin
Risankizumab-rzaa
Risankizumab-rzaa
Adalimumab
Paricalcitol
risankizumab-rzaa
leuprolide acetate
leuprolide acetate
Upadacitinib
Upadacitinib
Upadacitinib
Ritonavir
ABBVIE INC.
AbbVie Inc.
ABBVIE INC.
ABBVIE INC.
ABBVIE INC.
ABBVIE INC.
2021-09-17
2021-10-18
2021-09-20
2021-09-07
2021-09-17
2021-09-17
2021-09-14
2021-09-14
2021-09-17
2021-09-17
2021-09-20
2021-10-19
2021-10-19
2021-10-19
2021-10-19
2021-10-19
2021-10-19
2021-10-18
2021-10-18
2021-10-18
2021-10-18
2021-10-18
2021-10-18
2021-10-18
2021-10-18
2019-04-15
2022-12-07
2022-07-07
2021-10-19
2021-10-19
2021-10-19
2021-10-19
2021-10-19
2021-10-19
2021-10-18
2021-10-18
2021-10-18
2021-10-18
2021-10-18
2021-10-18